PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS

Clinical trials for PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS explained in plain language.

Never miss a new study

Get alerted when new PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS trials appear

Sign up with your email to follow new studies for PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Completed 1

Extended trial offers hope for kids battling rare liver disease

Disease control Completed

This study followed children with a rare, inherited liver disease called PFIC to see if a drug called odevixibat (A4250) remained safe and effective over a long period. The 116 participants, who had previously been in a shorter trial, took the drug for up to 72 weeks. Researchers…

Matched conditions: PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS

Phase: PHASE3 • Sponsor: Albireo, an Ipsen Company • Aim: Disease control

Last updated Apr 02, 2026 00:57 UTC

PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS

Get alerted when new PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS trials appear

Extended trial offers hope for kids battling rare liver disease